DLR Global X US Dollar Currency ETF

NOT FOR DISSEMINATION IN THE UNITED STATES OF AMERICA.

Premier Diagnostic Health Services Inc. ("Premier" or the "Company") (CNSX:PDH)
is pleased to announce the third quarter operating results ended June 30, 2013,
of the Company's clinic located at the Beijing Military Police Hospital #3 (the
"Beijing Hospital"). The MRI Clinic, operating under the Company's brand "Center
for Advanced Diagnostics" is owned and operated, as a Cooperative Joint Venture
with the Hospital. It is a full service MRI diagnostic clinic and employs a
staff of 10 people.


Medical diagnostic scans at the Clinic, opened in October 2010, have enjoyed
significant growth, increasing from approximately 150 scans per month to more
than 1200 scans per month during the last quarter of operations. The Clinic is
currently operating 12 hours per day and 7 days as week. During the last 3
quarters of operation the clinic has generated net revenue to the Company of
more than US$ 330,000. 


Premier is also pleased to announce that, based upon the exceptional operating
results of its Beijing Clinic, the experience it has gained in the China market
and recent announcements by the Chinese government encouraging foreign
investment in the health care industry, Premier is undertaking a review of its
structure, operations and financing opportunities in China. 


In this regard, the Company has retained DLR Capital Corporation ("DLR"), a
management consulting firm, to provide advice and assistance in reorganizing the
Company's Hong Kong operations, planning the expansion of the Company's
diagnostic business in China and preparing a new business and financial plan. In
consideration of the consulting services, DLR will receive a service fee of
$50,000 payable by issue of 1,000,000 shares at an issue price of $0.05 per
share. The Common shares will be subject to a 4 month hold period from the date
of issue of the Shares. Ian D. Robertson, a director of Premier and an officer
and director of DLR, will guide the process. 


Denis Tusar, in announcing the results of the Beijing Clinic and organizational
review stated: "We have spent five long and lean years learning about the health
care business in China, how to operate profitably in the market, developing
great relationships with various levels of government, and building a strong and
dedicated team. It is now time to take what we have learned and implement the
plan to aggressively grow our business in China."


About Premier Diagnostic Health Services Inc. ("PDH")

PHD is a Canadian company that provides advanced medical diagnostic tools
utilizing of PET/CT Technology and/or MRI Technology and related diagnostic
skills in Canada and, in partnership with hospitals and clinics in the Peoples
Republic of China. The company's vision is to provide services and that support
"improving medical decisions" around the world. The company's approach involves
building long-term relationships covering management, quality, and financial
services that are necessary to build, operate, and grow hospitals' and Clinics'
diagnostic capacity and capability. 


The Canadian National Stock Exchange has neither approved nor disapproved the
contents of this press release. Except for historical information contained
herein, this news release contains forward-looking statements that involve risks
and uncertainties. Actual results may differ materially. More detailed
information about potential factors that could affect financial results is
included in the documents filed from time to time with the Canadian securities
regulatory authorities by Premier. 


FOR FURTHER INFORMATION PLEASE CONTACT: 
Premier Diagnostic Health Services Inc
Denis Tusar
President & CEO
(604) 678.9120 Ext. 225
(604) 678.9278 (FAX)
dtusar@premierdiagnostics.ca


Premier Diagnostic Health Services Inc
Daniel Waters
Investor Relations
(604) 678.9120 Ext. 236
(604) 678.9278 (FAX)
dwaters@premierdiagnostics.ca
www.premierdiagnostics.ca

Global X US Dollar Curre... (TSX:DLR)
Historical Stock Chart
From Nov 2024 to Dec 2024

Global X US Dollar Curre... (TSX:DLR)
Historical Stock Chart
From Dec 2023 to Dec 2024